A new type of cell therapy helped dramatically reduce serious liver-related complications that could lead to hospitalisation and death in patients with liver scarring, or cirrhosis.

The innovative new approach, by researchers at the University of Edinburgh in the UK, uses macrophage immune cells -- the cells associated with tissue repair -- derived from the patient`s own cells to treat cirrhosis.